References
Original article
Zhou, C. et al. Amivantamab plus chemotherapy in NSCLC with EGFR exon 20 insertions. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2306441 (2023)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Killock, D. From CHRYSALIS to PAPILLON: the metamorphosis of amivantamab into frontline therapy for NSCLC. Nat Rev Clin Oncol 21, 5 (2024). https://doi.org/10.1038/s41571-023-00839-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-023-00839-x
- Springer Nature Limited